Q2 FY2026 · ended Jun 30, 2026 · Revenue $0 · Filed Aug 11, 2026
Adagio Medical Holdings, Inc. (ADGM) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $0 and a net loss of $6.7 million. Free cash flow was -$5.3 million. As of Jun 30, 2026 it held $7.7 million in cash and investments and $26.0 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ADGM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Laguna Hills, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2006986
- Former names
- Aja Holdco, Inc. (until Aug 1, 2024)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — |
| Operating income | -$4.9M | -$5.2M | -$4.0M | -$5.7M | -$4.7M |
| Net income | -$6.7M | -$7.0M | -$3.3M | -$10.1M | -$3.9M |
| Diluted EPS | -$0.30 | -$0.31 | -$0.16 | -$0.66 | -$0.35 |
| Operating cash flow | -$5.3M | -$4.1M | -$4.1M | -$3.0M | -$4.7M |
| Free cash flow | -$5.3M | -$4.1M | -$4.6M | -$3.5M | -$4.7M |
| Total assets | $33.9M | $39.3M | $43.3M | $31.5M | $35.9M |
| Total liabilities | $34.3M | $33.6M | $30.9M | $32.9M | $27.2M |
| Stockholders' equity | -$415,000 | $5.7M | $12.4M | -$1.3M | $8.7M |
| Cash and investments | $7.7M | $12.9M | $17.1M | $4.7M | $8.2M |
| Total debt | $26.0M | $24.1M | $21.8M | $22.0M | $17.8M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 5, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Oct 26, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Oct 1, 2026 | Sep 25, 2026 |
| 8-K |
Current report
Exit or restructuring costs, Other events
|
Sep 23, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Listing notice
|
Aug 14, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 13, 2026 | Aug 13, 2026 |
All 234 Adagio Medical Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.